Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GPO Legislation Waits For March 15 Deadline; Masimo v. Tyco Opens In L.A.

This article was originally published in The Gray Sheet

Executive Summary

Senate Judiciary/Antitrust Subcommittee Chair Mike DeWine (R-Ohio) and Ranking Democrat Herb Kohl (Wis.) will consider GPO comments through March 15 in weighing potential changes to the "Medical Device Competition Act" for re-introduction this year

You may also be interested in...



Senate Antitrust/Judiciary Staffer Probes For “Teeth” In GPO Initiative

The GPO industry must define penalties for departing from self-imposed ethical standards if group purchasing organizations want to avoid legislation, Senate staffer Seth Bloom suggested May 17

Senate Antitrust/Judiciary Staffer Probes For “Teeth” In GPO Initiative

The GPO industry must define penalties for departing from self-imposed ethical standards if group purchasing organizations want to avoid legislation, Senate staffer Seth Bloom suggested May 17

GPOs May Spurn Anti-Competitive Contracts After Masimo v. Tyco – MDMA

Masimo believes its $420 mil. legal victory over Tyco will spur large manufacturers and GPOs to gradually alter their business practices, resulting in long-term cost savings for hospitals

Related Content

UsernamePublicRestriction

Register

MT021682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel